PATENT CLAIM ANALYSIS

Application Number: 16135540
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["435", "235100"]

Abstract:
The invention provides a targeted bacteriophage-polymer complex comprising a recombinant targeted-bacteriophage and a cationic polymer. The complex has a net positive charge. The invention provides methods of preparing bacteriophages and complexes thereof, and to their uses for the delivery of transgenes in a variety of gene therapy applications.

Claim (Index 44):
The method of  claim 43 , wherein the mean particle size of the aggregate is between about 600 nm and 2500 nm, or between about 600 nm and 1500 nm, or between about 700 nm and 1200 nm.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 97.0
- Lexical Diversity: 1.40541
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13403765', '12714147', '10530168', '14223944', '15380734']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6220773020424425
- 35 USC 102 Novelty (BERT): 0.5295027439905495
- Combined Prediction Score: 0.6128198462372533
- Mean Citation Score: 247.124258
- Max Citation Score: 314.16943
- Similarity Product: 138.22218931916058

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test